ALIGOS THERAPEUTICS, INC. (ALGS)
Clinical trial NCT07342868 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-05-05 → 2026-08-19 3. primary completion date: 2026-04-20 → 2026-08-19 4. enrollment: 16 → 20 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical